Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE45.8400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots29.6300/ 1
- Ask / Lots51.4600/ 8
- Open / Previous Close0.0000 / 45.8400
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 4639 | 47.13 |
| 09:34 ET | 2017 | 46.8614 |
| 09:38 ET | 2100 | 46.675 |
| 09:39 ET | 981 | 46.36 |
| 09:41 ET | 1100 | 46.625 |
| 09:45 ET | 615 | 46.52 |
| 09:48 ET | 100 | 46.42 |
| 09:52 ET | 700 | 46.305 |
| 09:54 ET | 100 | 46.395 |
| 09:56 ET | 5395 | 46.96 |
| 09:57 ET | 10257 | 47.36 |
| 09:59 ET | 4618 | 46.97 |
| 10:01 ET | 522 | 46.88 |
| 10:03 ET | 1558 | 46.92 |
| 10:06 ET | 1684 | 46.95 |
| 10:08 ET | 1221 | 47.07 |
| 10:10 ET | 1300 | 47.03 |
| 10:12 ET | 3150 | 47.23 |
| 10:14 ET | 500 | 47.21 |
| 10:15 ET | 700 | 47.225 |
| 10:17 ET | 2548 | 47 |
| 10:19 ET | 1900 | 47.07 |
| 10:21 ET | 100 | 47 |
| 10:24 ET | 3948 | 47.1 |
| 10:26 ET | 5859 | 47.005 |
| 10:28 ET | 5283 | 46.99 |
| 10:30 ET | 4459 | 47.05 |
| 10:32 ET | 4684 | 47 |
| 10:33 ET | 646 | 47.06 |
| 10:35 ET | 200 | 47.05 |
| 10:37 ET | 3100 | 47.1 |
| 10:39 ET | 46868 | 46.98 |
| 10:42 ET | 7777 | 46.9 |
| 10:44 ET | 7195 | 46.82 |
| 10:46 ET | 100 | 46.805 |
| 10:48 ET | 1595 | 47.01 |
| 10:50 ET | 104 | 46.99 |
| 10:51 ET | 3163 | 47.06 |
| 10:53 ET | 975 | 47.06 |
| 10:55 ET | 2500 | 46.72 |
| 10:57 ET | 599 | 46.73 |
| 11:00 ET | 1236 | 46.71 |
| 11:02 ET | 100 | 46.85 |
| 11:04 ET | 603 | 46.9 |
| 11:06 ET | 775 | 46.795 |
| 11:08 ET | 100 | 46.8 |
| 11:09 ET | 6538 | 47.06 |
| 11:11 ET | 200 | 47.02 |
| 11:13 ET | 1291 | 47.01 |
| 11:15 ET | 950 | 47.05 |
| 11:20 ET | 682 | 47.07 |
| 11:22 ET | 200 | 47.01 |
| 11:24 ET | 854 | 47.07 |
| 11:26 ET | 25598 | 46.86 |
| 11:27 ET | 100 | 46.86 |
| 11:31 ET | 1678 | 46.975 |
| 11:33 ET | 897 | 46.88 |
| 11:36 ET | 1000 | 46.89 |
| 11:38 ET | 327 | 46.85 |
| 11:40 ET | 103 | 46.855 |
| 11:42 ET | 1445 | 46.6 |
| 11:44 ET | 600 | 46.475 |
| 11:47 ET | 200 | 46.47 |
| 11:54 ET | 500 | 46.32 |
| 11:56 ET | 2200 | 46.395 |
| 11:58 ET | 613 | 46.39 |
| 12:02 ET | 7388 | 46.28 |
| 12:03 ET | 2054 | 46.18 |
| 12:05 ET | 1429 | 46.245 |
| 12:07 ET | 787 | 46.23 |
| 12:09 ET | 400 | 46.33 |
| 12:12 ET | 500 | 46.26 |
| 12:14 ET | 400 | 46.19 |
| 12:16 ET | 600 | 46.1925 |
| 12:18 ET | 800 | 46.08 |
| 12:20 ET | 100 | 46.1 |
| 12:21 ET | 100 | 46.055 |
| 12:23 ET | 700 | 46.08 |
| 12:25 ET | 2766 | 46.02 |
| 12:27 ET | 2750 | 46.21 |
| 12:30 ET | 300 | 46.15 |
| 12:34 ET | 100 | 46.15 |
| 12:38 ET | 700 | 46.11 |
| 12:39 ET | 200 | 46.09 |
| 12:41 ET | 788 | 46.14 |
| 12:45 ET | 9900 | 46.12 |
| 12:48 ET | 700 | 46.125 |
| 12:50 ET | 673 | 46.22 |
| 12:52 ET | 400 | 46.27 |
| 12:54 ET | 4111 | 46.297 |
| 12:57 ET | 576 | 46.31 |
| 12:59 ET | 1150 | 46.405 |
| 01:01 ET | 220 | 46.43 |
| 01:08 ET | 511 | 46.315 |
| 01:10 ET | 200 | 46.34 |
| 01:12 ET | 200 | 46.31 |
| 01:14 ET | 200 | 46.325 |
| 01:17 ET | 1190 | 46.38 |
| 01:19 ET | 100 | 46.43 |
| 01:21 ET | 300 | 46.445 |
| 01:24 ET | 500 | 46.38 |
| 01:26 ET | 304 | 46.475 |
| 01:28 ET | 3300 | 46.55 |
| 01:30 ET | 4882 | 46.695 |
| 01:32 ET | 4600 | 46.68 |
| 01:33 ET | 120 | 46.64 |
| 01:35 ET | 300 | 46.64 |
| 01:37 ET | 378 | 46.66 |
| 01:44 ET | 990 | 46.76 |
| 01:46 ET | 100 | 46.755 |
| 01:48 ET | 628 | 46.79 |
| 01:50 ET | 700 | 46.76 |
| 01:51 ET | 266 | 46.83 |
| 01:53 ET | 700 | 46.89 |
| 01:55 ET | 2546 | 46.92 |
| 01:57 ET | 100 | 46.94 |
| 02:00 ET | 2442 | 46.95 |
| 02:02 ET | 100 | 46.975 |
| 02:04 ET | 4841 | 46.96 |
| 02:06 ET | 300 | 46.97 |
| 02:08 ET | 1100 | 46.76 |
| 02:09 ET | 200 | 46.74 |
| 02:11 ET | 1519 | 46.85 |
| 02:13 ET | 937 | 46.74 |
| 02:18 ET | 2375 | 46.81 |
| 02:22 ET | 900 | 46.76 |
| 02:24 ET | 554 | 46.755 |
| 02:26 ET | 1040 | 46.705 |
| 02:27 ET | 408 | 46.805 |
| 02:29 ET | 680 | 46.83 |
| 02:31 ET | 200 | 46.85 |
| 02:33 ET | 900 | 46.88 |
| 02:36 ET | 2784 | 46.71 |
| 02:38 ET | 200 | 46.75 |
| 02:40 ET | 954 | 46.88 |
| 02:42 ET | 644 | 46.85 |
| 02:44 ET | 900 | 46.83 |
| 02:45 ET | 604 | 46.815 |
| 02:47 ET | 872 | 46.8 |
| 02:49 ET | 600 | 46.87 |
| 02:51 ET | 1549 | 46.75 |
| 02:54 ET | 600 | 46.73 |
| 02:56 ET | 500 | 46.76 |
| 02:58 ET | 2500 | 46.7 |
| 03:00 ET | 500 | 46.68 |
| 03:02 ET | 400 | 46.57 |
| 03:03 ET | 200 | 46.505 |
| 03:05 ET | 394 | 46.5014 |
| 03:07 ET | 519 | 46.54 |
| 03:09 ET | 800 | 46.45 |
| 03:12 ET | 100 | 46.46 |
| 03:14 ET | 600 | 46.42 |
| 03:16 ET | 437 | 46.44 |
| 03:18 ET | 1622 | 46.5 |
| 03:20 ET | 3914 | 46.46 |
| 03:21 ET | 527 | 46.3 |
| 03:23 ET | 1888 | 46.26 |
| 03:25 ET | 702 | 46.21 |
| 03:27 ET | 238 | 46.2 |
| 03:30 ET | 12967 | 46.14 |
| 03:32 ET | 900 | 46.145 |
| 03:34 ET | 747 | 46.23 |
| 03:36 ET | 3025 | 46.13 |
| 03:38 ET | 818 | 46.08 |
| 03:39 ET | 501 | 46.09 |
| 03:41 ET | 500 | 46 |
| 03:43 ET | 887 | 45.97 |
| 03:45 ET | 854 | 46.02 |
| 03:48 ET | 2640 | 45.96 |
| 03:50 ET | 2451 | 45.92 |
| 03:52 ET | 3132 | 46.08 |
| 03:54 ET | 3055 | 45.96 |
| 03:56 ET | 4143 | 45.9 |
| 03:57 ET | 4454 | 45.85 |
| 03:59 ET | 112086 | 45.84 |
Jun 4, 2024
DJ Crinetics Pharmaceuticals Price Target Maintained With a $80.00/Share by JMP Securities, from 8:29AM ET on Tuesday Jun 04, 2024 by Dow Jones
8:29AM ET on Tuesday Jun 04, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Is Maintained at Outperform by Oppenheimer, from 8:19AM ET on Tuesday Jun 04, 2024 by Dow Jones
8:19AM ET on Tuesday Jun 04, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Price Target Maintained With a $60.00/Share by HC Wainwright & Co., from 7:37AM ET on Tuesday Jun 04, 2024 by Dow Jones
7:37AM ET on Tuesday Jun 04, 2024 by Dow Jones
Jun 3, 2024
Crinetics Presents New Data at ENDO 2024 that Increases Body of Evidence Positioning Once-Daily, Oral Paltusotine as Potential First-Choice Treatment Option for Acromegaly, from 12:00PM ET on Monday Jun 03, 2024 by Dow Jones
12:00PM ET on Monday Jun 03, 2024 by Dow JonesCrinetics Announces Positive Initial Findings at ENDO 2024 for Atumelnant in Two Ongoing, Open-Label Studies for the Treatment of Congenital Adrenal Hyperplasia (CAH) and ACTH-Dependent Cushing's Syndrome (ADCS), from 12:00PM ET on Monday Jun 03, 2024 by Dow Jones
12:00PM ET on Monday Jun 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 3.5B | -12.2x | --- |
Immunovant Inc | 3.7B | -13.5x | --- |
Merus NV | 3.6B | -19.7x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Dyne Therapeutics Inc | 3.1B | -8.2x | --- |
Biohaven Ltd | 3.1B | -4.9x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- President, Chief Executive Officer, Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.5B |
|---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.65 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -12.2x |
Price/Sales (TTM) | 1,774.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
